New combo therapy shows promise against rare childhood lymphoma
NCT ID NCT01516567
First seen Feb 13, 2026 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tested a treatment called DA-EPOCH-Rituximab in 47 children and teens with a rare type of lymphoma (PMLBL). The goal was to see if this combination of chemotherapy and a targeted antibody could improve how long patients stay cancer-free. Participants received the drug regimen, and researchers tracked survival, side effects, and long-term health. The trial is complete, and results help guide future treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
2nd Dept. of Pediatrics Semmelweis Univ.
Budapest, 1094, Hungary
-
Associazione Italiana di Ematologia ed Oncologia Pediatrica
Padova, 35128, Italy
-
Children Oncology Group Operations centres
Monrovia, Canada
-
Emma Children's Hospital
Amsterdam, 1105 AZ, Netherlands
-
Gustave Roussy
Villejuif, 94805, France
-
Rectorat of Medical University
Wroclaw, Poland
-
Sociedad Española de Hematología y Oncología Pediátricas
Valencia, 46010, Spain
-
University Hospitals Leuven
Leuven, 3000, Belgium
-
University of Birmingham
Birmingham, United Kingdom
Conditions
Explore the condition pages connected to this study.